Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 316

Lim links up with SGInnovate

Former NTUitive chief executive Jui Lim will lead the Singaporean government's deep tech-focused investment unit from this May.

Mar 26, 2020

Daily deal net: March 25, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Mar 25, 2020

CVC in the Time of Coronavirus: Donald Lacey, Ping An Global Voyager…

The Ping An subsidiary is providing strategic assistance to portfolio companies during the Covid-19 pandemic, though managing director Lacey cautioned that startups with high burn rates are facing high risk.

Mar 25, 2020

Frontier IP banks $2.8m profit

Frontier IP's half-year profit rose 86% in dollars to the end of 2019 but its stocks are now under pressure in the current economic climate.

Mar 25, 2020

Abbisko absorbs $70m

Lilly Asia Ventures, an investor in the cancer drug developer since its series A round, returned to back a series C that doubled its overall funding to $140m.

Mar 25, 2020

Dragonfly Therapeutics drags financing to $300m

Dragonfly, whose co-founders include MIT and UC Berkeley faculty, has boosted its total financing to $300m in round of undisclosed size led by Fidelity.

Mar 25, 2020

Daily deal net: March 24, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Mar 24, 2020

CureFit cuts to $109m round

Unilever Ventures returned to back a round led by Temasek that expanded the health and wellness services platform's overall financing to approximately $390m.

Mar 24, 2020

Dragonfly Therapeutics drags financing to $300m

Celgene-backed immuno-oncology drug developer Dragonfly Therapeutics boosted its total financing to $300m in round of undisclosed size led by Fidelity.

Mar 24, 2020

Design unlocks $45m series A

University of Wisconsin-Madison gene medicine developer Design Therapeutics has attracted SR One for its series A round.

Mar 23, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here